Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approach [0.03%]
急性髓系白血病异基因造血干细胞移植的危险度分层策略
Tom Lodewyck,Jan J Cornelissen
Tom Lodewyck
Allogeneic hematopoietic stem cell transplantation (alloSCT) is nowadays most frequently applied in patients with acute myeloid leukemia (AML). It combines chemoradiotherapy with immunotherapy, also known as the graft-versus-leukemia (GVL) ...
Mechanisms for resistance to BCMA-targeted immunotherapies in multiple myeloma [0.03%]
靶向BCMA的免疫疗法在多发性骨髓瘤中的耐药机制
Multiple myeloma (MM) remains incurable and patients eventually face the relapse/refractory dilemma. B cell maturation antigen (BCMA)-targeted immunotherapeutic approaches have shown great effectiveness in patients with relapsed/refractory ...